Federation Des Caisses Desjardins Du Quebec Sio Gene Therapies Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Aug 30, 2024	SELL	$1.81 - $2.7 $4,163 - $6,210	-2,300 Closed	0 $0
Q2 2021 Aug 30, 2024	BUY	$2.07 - $2.89 $4,761 - $6,647	2,300 New	2,300 $6.28 Million
Q4 2020 Aug 30, 2024	BUY	$1.91 - $5.63 $4,393 - $12,949	2,300 New	2,300 $6.39 Million

Others Institutions Holding SIOX

# of Institutions

Shares Held

147K

Call Options Held

Put Options Held

Act Capital Management, LLC Wayne, PA

147K
Shares

$0
0.06% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Sio Gene Therapies Inc.

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

More about SIOX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account